CERE
Cerevel Therapeutics Holdings Inc

3,251
Loading...
Loading...
News
all
press releases
CERE Investors Have Opportunity to Join Cerevel Therapeutics Holdings, Inc. Fraud Investigation with the Schall Law Firm
The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Cerevel Therapeutics Holdings, Inc. (Cerevel or the Company...
Business Wire·7mo ago
News Placeholder
More News
News Placeholder
As Traumatic Brain Injuries Increase, Global Concussion Market Size Expected to Reach $10 Billion By 2032
As Traumatic Brain Injuries Increase, Global Concussion Market Size Expected to Reach $10 Billion By 2032 As Traumatic Brain Injuries Increase, Global Concussion Market Size Expected to Reach $10...
PR Newswire·1y ago
News Placeholder
CERE Investors Have the Opportunity to Join Investigation of Cerevel Therapeutics Holdings, Inc. with the Schall Law Firm
CERE Investors Have the Opportunity to Join Investigation of Cerevel Therapeutics Holdings, Inc. with the Schall Law Firm CERE Investors Have the Opportunity to Join Investigation of Cerevel...
PR Newswire·1y ago
News Placeholder
CERE Investors Have the Opportunity to Join Investigation of Cerevel Therapeutics Holdings, Inc. with the Schall Law Firm
The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors in Cerevel Therapeutics Holdings, Inc. (Cerevel or the Company...
Business Wire·1y ago
News Placeholder
CEREVEL SHAREHOLDER ALERT: Kaskela Law LLC Announces Investigation into Fairness of Cerevel Therapeutics Holdings, Inc. (NASDAQ: CERE) Buyout and Encourages Investors to Contact the Firm
Kaskela Law LLC announces that it is investigating Cerevel Therapeutics Holdings, Inc. (NASDAQ: CERE) (Cerevel) on behalf of the companys shareholders. On December 6, 2023, Cerevel announced that it...
Business Wire·1y ago
News Placeholder
Calling All Cerevel Therapeutics Holdings, Inc. (CERE) Investors: Contact Bronstein, Gewirtz & Grossman, LLC To Claim Your Losses
Attorney Advertising--Bronstein, Gewirtz & Grossman, LLC is investigating the merger between Cerevel Therapeutics Holdings, Inc. ('Cerevel') (NASDAQ: CERE) and AbbVie, Inc. (AbbVie) (NYSE: ABBV...
Business Wire·1y ago
News Placeholder
CEREVEL INVESTOR NOTICE: Kaskela Law LLC Announces Investigation of Cerevel Therapeutics Holdings, Inc. (NASDAQ: CERE) and Encourages Investors to Contact the Firm
CEREVEL INVESTOR NOTICE: Kaskela Law LLC Announces Investigation of Cerevel Therapeutics Holdings, Inc. (NASDAQ: CERE) and Encourages Investors to Contact the Firm CEREVEL INVESTOR NOTICE: Kaskela...
PR Newswire·1y ago
News Placeholder
Calling All Cerevel Therapeutics Holdings, Inc. (CERE) Investors: Contact Bronstein, Gewirtz & Grossman, LLC To Claim Your Losses
Attorney Advertising-- Bronstein, Gewirtz & Grossman, LLC is investigating the merger between Cerevel Therapeutics Holdings, Inc. ('Cerevel') (NASDAQ: CERE) and AbbVie, Inc. (AbbVie) (NYSE: ABBV...
Business Wire·1y ago
News Placeholder
NOTICE OF INVESTIGATION: Kaskela Law LLC Announces Shareholder Investigation of Cerevel Therapeutics Holdings, Inc. (NASDAQ: CERE) and Encourages Investors to Contact the Firm
NOTICE OF INVESTIGATION: Kaskela Law LLC Announces Shareholder Investigation of Cerevel Therapeutics Holdings, Inc. (NASDAQ: CERE) and Encourages Investors to Contact the Firm NOTICE OF...
PR Newswire·1y ago
News Placeholder
Director N Coles Sells 50,000 Shares of Cerevel Therapeutics Holdings Inc (CERE)
Related Stocks: CERE...
GuruFocus·1y ago

Latest CERE News

View

Advertisement. Remove ads.

Advertisement. Remove ads.